Neogenomics Inc (NEO) 8.32 $NEO Fate Therapeutics (FATE)

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 11:07 AM

Neogenomics Inc (NEO) 8.32 $NEO

Fate Therapeutics (FATE) Catches Eye: Stock Jumps 19.1%
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 7:25AM CDT
Fate Therapeutics, Inc. (FATE) moved big last session, as its shares jumped over 19% on the day.
FATE: 1.80 (-0.03), NEO: 8.32 (-0.08)

Zacks Investment Ideas feature highlights: Neogenomics, AMN Healthcare Services, Glaukos, National Commerce and NMI Holdings
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:30AM CDT
Zacks Investment Ideas feature highlights: Neogenomics, AMN Healthcare Services, Glaukos, National Commerce and NMI Holdings
GKOS: 28.71 (-0.61), NEO: 8.32 (-0.08), NCOM: 24.08 (+0.31), AHS: 40.11 (+0.63)

5 Great Growth Stocks To Buy Now
Brian Bolan - ZACKS - Fri Jun 17, 12:57PM CDT
5 Great Growth Stocks To Buy Now
GKOS: 28.71 (-0.61), NEO: 8.32 (-0.08), NCOM: 24.08 (+0.31), AHS: 40.11 (+0.63), NMIH: 5.60 (+0.13)

Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:30AM CDT
Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
PMC: 24.56 (+0.15), UNFI: 45.60 (+0.61), NEO: 8.32 (-0.08), BWP: 17.77 (+0.04), WTW: 13.36 (+0.19)

Bet on These 5 Stocks with Upgraded Broker Ratings
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:14AM CDT
After thorough research, brokers decide to rate that particular company's stock. Naturally, when an analyst upgrades a stock, you can easily rely on it.
PMC: 24.56 (+0.15), UNFI: 45.60 (+0.61), NEO: 8.32 (-0.08), BWP: 17.77 (+0.04), WTW: 13.36 (+0.19)

Neogenomics (NEO) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:54AM CDT
Neogenomics Inc. (NEO) has been struggling lately, but the selling pressure may be coming to an end soon
NEO: 8.32 (-0.08)

Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:30AM CDT
Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
NTES: 169.50 (+1.97), NEO: 8.32 (-0.08), CVGI: 5.30 (+0.10)

Explosive Returns with the Filtered Zacks Rank 5 Strategy
Kevin Matras - ZACKS - Tue Jun 07, 3:38PM CDT
Explosive Returns with the Filtered Zacks Rank 5 Strategy
NTES: 169.50 (+1.97), NEO: 8.32 (-0.08), CVGI: 5.30 (+0.10)

Bet on These 5 Liquid Stocks for Fat Returns
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 12:23PM CDT
An efficient company with a favorable liquidity level may prove to be a profitable addition to one's portfolio.
NEO: 8.32 (-0.08), SLAB: 50.11 (+0.79), NTGR: 48.25 (+0.50), LPLA: 25.62 (+0.62), AMPH: 15.86 (+0.27)

The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:30AM CDT
The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
CSGP: 212.04 (+2.34), AMSF: 61.31 (+0.59), NEO: 8.32 (-0.08), HIIQ: 4.40 (-0.01), AHS: 40.11 (+0.63)

7 Stocks with Recent Price Strength to Boost Your Returns
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 9:24AM CDT
Stocks that have recently seen price strength have high chances of carrying the momentum forward.
AMSF: 61.31 (+0.59), NEO: 8.32 (-0.08), HIIQ: 4.40 (-0.01), AHS: 40.11 (+0.63), COHR: 93.25 (+1.22), NANO: 20.60 (+0.24)

Integra (IART): Strong Revenue Growth on Global Prospects
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:16AM CDT
On May 31, 2016, we issued an updated research report on Plainsboro, NJ-based Integra LifeSciences Holdings Corporation (IART).
IART: 76.14 (+0.82), ANIP: 55.61 (+2.82), NEO: 8.32 (-0.08), RTRX: 18.48 (unch)

Earnings Estimates Moving Higher for Neogenomics (NEO): Time to Buy?
Zacks Equity Research - Zacks Investment Research - Thu May 26, 7:42AM CDT
Neogenomics (NEO) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
NEO: 8.32 (-0.08)

Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 76.14 (+0.82), HSKA: 33.86 (-0.04), ANIP: 55.61 (+2.82), NEO: 8.32 (-0.08)

NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains
PR Newswire - Wed Apr 27, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the first quarter of 2016.
NEO: 8.32 (-0.08)

Investor Calendar Invites You to the NeoGenomics First Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday April 27, 2016
ACCESSWIRE - Tue Apr 26, 3:05PM CDT
FORT MYERS, FL / ACCESSWIRE / April 26, 2016 / NeoGenomics, Inc. (NASDAQ: NEO) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Wednesday, April 27, 2016 at 11:00 AM Eastern Time.
NEO: 8.32 (-0.08)

NeoGenomics Schedules its Q1 2016 Earnings Release for April 27, 2016
PR Newswire - Mon Apr 11, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO) announced today that it plans to release its first quarter 2016 financial results on Wednesday April 27, 2016.
NEO: 8.32 (-0.08)

Pressure BioSciences' SCIEX Deal Could Dramatically Accelerate Revenue
ACCESSWIRE - Thu Jan 28, 8:26AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 28, 2016 / SCIEX, a global leader in life science analytical technologies, and a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR), recently announced an exclusive co-marketing agreement with Pressure BioSciences, Inc. (OTCQB: PBIO). PBIO is a worldwide leader in the development and sale of pressure cycling technology (PCT)-based sample preparation systems to the life sciences research market. Under the agreement, the companies will jointly promote PBIO's PCT-based sample preparation systems and SCIEX's mass spectrometry equipment, with a focus on improved sample preparation, a crucial step performed by hundreds of thousands of research laboratories worldwide. This combination of technologies could result in superior biological insights and discoveries in the life sciences industry, and in rapid and dramatic revenue growth for PBIO.
NSTG: 13.63 (+0.11), A: 46.49 (+0.46), TMO: 151.30 (+1.45), NEO: 8.32 (-0.08), QGEN: 21.86 (+0.11), DHR: 99.78 (+0.74), WAT: 138.45 (+1.22)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

EMCO's New Automated Facility Could Shake Industry

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Duke Energy's Cost-Protection Plan Shields Ratepayers

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Vitamin Angels Drives Global Nutrition Advancements

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

HelloNation Brings 'Edvertising' to NC REALTORS® Event

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

C3EL Expands Federal Footprint with Strategic Contracts

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Merit Expands in New York with Bold Acquisition Move

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...